Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

US Patent 12129294 · Granted Oct 29, 2024

Estimated economic value: $2,113,225,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treatment of diseases in which IL-13 activity is detrimental using an2024
Methods of treatment of diseases in which IL-13 activity is detrimental using an2024
Methods of treatment of diseases in which IL-13 activity is detrimental using an2024
Methods of treatment of diseases in which IL-13 activity is detrimental using an2024
Methods of treatment of diseases in which IL-13 activity is detrimental using an2022
Methods of treatment of diseases in which IL-13 activity is detrimental using an2022
Methods of treatment of diseases in which IL-13 activity is detrimental using an2022
Methods of treatment of diseases in which IL-13 activity is detrimental using an2022
Compounds and methods for treating lupus2022
BSL2v2c2-Ig polypeptides2020
B7-related nucleic acids and polypeptides useful for immunomodulation2019
Methods of treatment using CTLA4 mutant molecules2019